These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20305688)

  • 1. Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer.
    Pontier SM; Huck L; White DE; Rayment J; Sanguin-Gendreau V; Hennessy B; Zuo D; St-Arnaud R; Mills GB; Dedhar S; Marshall CJ; Muller WJ
    Oncogene; 2010 Jun; 29(23):3374-85. PubMed ID: 20305688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
    White DE; Cardiff RD; Dedhar S; Muller WJ
    Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-opted integrin signaling in ErbB2-induced mammary tumor progression.
    Carraway KL; Sweeney C
    Cancer Cell; 2006 Aug; 10(2):93-5. PubMed ID: 16904607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
    Huck L; Pontier SM; Zuo DM; Muller WJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15559-64. PubMed ID: 20713705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of malignant growth of human breast cancer cells by ectopic expression of integrin-linked kinase.
    Chen P; Shen WZ; Karnik P
    Int J Cancer; 2004 Oct; 111(6):881-91. PubMed ID: 15300800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population.
    Pratt MA; Tibbo E; Robertson SJ; Jansson D; Hurst K; Perez-Iratxeta C; Lau R; Niu MY
    Oncogene; 2009 Jul; 28(30):2710-22. PubMed ID: 19483731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the negative regulator LRIG1 contributes to ErbB2 overexpression in breast cancer.
    Miller JK; Shattuck DL; Ingalla EQ; Yen L; Borowsky AD; Young LJ; Cardiff RD; Carraway KL; Sweeney C
    Cancer Res; 2008 Oct; 68(20):8286-94. PubMed ID: 18922900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
    Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
    Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
    Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
    Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrin-linked kinase (ILK) suppresses anoikis.
    Attwell S; Roskelley C; Dedhar S
    Oncogene; 2000 Aug; 19(33):3811-5. PubMed ID: 10949937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
    Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine PDGFR signaling promotes mammary cancer metastasis.
    Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
    J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
    Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
    Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
    Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ
    Cancer Res; 2003 Aug; 63(16):4920-6. PubMed ID: 12941816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.